Neovacs   Report issue

For profit Phase 2
Founded: Paris France (1993)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2008
NCT00808262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now